These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 34729540)

  • 1. Rapid inactivation of SARS-CoV-2 with LED irradiation of visible spectrum wavelengths.
    De Santis R; Luca V; Näslund J; Ehmann RK; De Angelis M; Lundmark E; Nencioni L; Faggioni G; Fillo S; Amatore D; Regalbuto E; Molinari F; Petralito G; Wölfel R; Stefanelli P; Rezza G; Palamara AT; Antwerpen M; Forsman M; Lista F
    J Photochem Photobiol; 2021 Dec; 8():100082. PubMed ID: 34729540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation of SARS-CoV-2 inactivation using a deep ultraviolet light-emitting diode.
    Minamikawa T; Koma T; Suzuki A; Mizuno T; Nagamatsu K; Arimochi H; Tsuchiya K; Matsuoka K; Yasui T; Yasutomo K; Nomaguchi M
    Sci Rep; 2021 Mar; 11(1):5070. PubMed ID: 33658595
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wu Y; Yao M
    Chin Sci Bull; 2014; 59(13):1438-1445. PubMed ID: 32214745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocarditis following COVID-19 vaccination: magnetic resonance imaging study.
    Shiyovich A; Witberg G; Aviv Y; Eisen A; Orvin K; Wiessman M; Grinberg T; Porter A; Kornowski R; Hamdan A
    Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1075-1082. PubMed ID: 34739045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell activation is associated with post-acute COVID-19 syndrome.
    Wechsler JB; Butuci M; Wong A; Kamboj AP; Youngblood BA
    Allergy; 2022 Apr; 77(4):1288-1291. PubMed ID: 34820848
    [No Abstract]   [Full Text] [Related]  

  • 6. Bowel Perforation in Covid-19 Case Series.
    Sciano D; D'Ambrosio R; Maresca A; Buonincontro S; Mariano F; Lenta A; D'Agostino A
    Ann Ital Chir; 2021; 92():589-591. PubMed ID: 34795115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host glycolipids in SARS-CoV-2 entry.
    Uraki R; Kawaoka Y
    Nat Chem Biol; 2022 Jan; 18(1):6-7. PubMed ID: 34754100
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased close proximity airborne transmission of the SARS-CoV-2 Delta variant.
    Mikszewski A; Stabile L; Buonanno G; Morawska L
    Sci Total Environ; 2022 Apr; 816():151499. PubMed ID: 34752865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination.
    Pastorino R; Pezzullo AM; Villani L; Causio FA; Axfors C; Contopoulos-Ioannidis DG; Boccia S; Ioannidis JPA
    Environ Res; 2022 Mar; 204(Pt C):112342. PubMed ID: 34748775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2, COVID-19 and the Ageing Immune System.
    Bartleson JM; Radenkovic D; Covarrubias AJ; Furman D; Winer DA; Verdin E
    Nat Aging; 2021 Sep; 1(9):769-782. PubMed ID: 34746804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease.
    Fedele G; Russo G; Schiavoni I; Leone P; Olivetta E; Perri V; Zingaropoli MA; Ciardi MR; Pasculli P; Mastroianni CM; Stefanelli P
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115586. PubMed ID: 34742119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the early COVID-19 cases in Wuhan.
    Worobey M
    Science; 2021 Dec; 374(6572):1202-1204. PubMed ID: 34793199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of FFP3 respirators for prevention of SARS-CoV-2 infection in healthcare workers.
    Ferris M; Ferris R; Workman C; O'Connor E; Enoch DA; Goldesgeyme E; Quinnell N; Patel P; Wright J; Martell G; Moody C; Shaw A; Illingworth CJ; Matheson NJ; Weekes MP
    Elife; 2021 Nov; 10():. PubMed ID: 34783656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice.
    Nanishi E; Borriello F; O'Meara TR; McGrath ME; Saito Y; Haupt RE; Seo HS; van Haren SD; Cavazzoni CB; Brook B; Barman S; Chen J; Diray-Arce J; Doss-Gollin S; De Leon M; Prevost-Reilly A; Chew K; Menon M; Song K; Xu AZ; Caradonna TM; Feldman J; Hauser BM; Schmidt AG; Sherman AC; Baden LR; Ernst RK; Dillen C; Weston SM; Johnson RM; Hammond HL; Mayer R; Burke A; Bottazzi ME; Hotez PJ; Strych U; Chang A; Yu J; Sage PT; Barouch DH; Dhe-Paganon S; Zanoni I; Ozonoff A; Frieman MB; Levy O; Dowling DJ
    Sci Transl Med; 2022 Jan; 14(629):eabj5305. PubMed ID: 34783582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank.
    Hou C; Hu Y; Yang H; Chen W; Zeng Y; Ying Z; Hu Y; Sun Y; Qu Y; Gottfreðsson M; Valdimarsdóttir UA; Song H
    BMC Med; 2021 Nov; 19(1):301. PubMed ID: 34781951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
    Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
    mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection, recovery and re-infection of farmed mink with SARS-CoV-2.
    Rasmussen TB; Fonager J; Jørgensen CS; Lassaunière R; Hammer AS; Quaade ML; Boklund A; Lohse L; Strandbygaard B; Rasmussen M; Michaelsen TY; Mortensen S; Fomsgaard A; Belsham GJ; Bøtner A
    PLoS Pathog; 2021 Nov; 17(11):e1010068. PubMed ID: 34780574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system.
    Khan T; Jamal SM
    Future Virol; 2021 Oct; ():. PubMed ID: 34777556
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lazarus R; Baos S; Cappel-Porter H; Carson-Stevens A; Clout M; Culliford L; Emmett SR; Garstang J; Gbadamoshi L; Hallis B; Harris RA; Hutton D; Jacobsen N; Joyce K; Kaminski R; Libri V; Middleditch A; McCullagh L; Moran E; Phillipson A; Price E; Ryan J; Thirard R; Todd R; Snape MD; Tucker D; Williams RL; Nguyen-Van-Tam JS; Finn A; Rogers CA;
    Lancet; 2021 Dec; 398(10318):2277-2287. PubMed ID: 34774197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
    Ella R; Reddy S; Blackwelder W; Potdar V; Yadav P; Sarangi V; Aileni VK; Kanungo S; Rai S; Reddy P; Verma S; Singh C; Redkar S; Mohapatra S; Pandey A; Ranganadin P; Gumashta R; Multani M; Mohammad S; Bhatt P; Kumari L; Sapkal G; Gupta N; Abraham P; Panda S; Prasad S; Bhargava B; Ella K; Vadrevu KM;
    Lancet; 2021 Dec; 398(10317):2173-2184. PubMed ID: 34774196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.